Clinical Trials Logo

Clinical Trial Summary

It is intended to evaluate the effect of a marketed cream (Alantel®) based on natural products at high concentrations for the preventive and curative treatment (early stages) of radiation-induced dermatitis in cancer patients. For this, an experimental, prospective, controlled clinical trial, with two parallel arms, double blind, multicentre, will be carried out in which doctors will recruit 78 patients aged 14 years or over in Primary Care consultations. more, diagnosed with cancer, and having received radiotherapeutic cancer treatment, being randomly assigned to the experimental group (cosmetic cream) or the control group (emollient and moisturizing cream). The main variable will be the incidence rate of mild post-translational dermatitis and its improvement or cure once it has been established.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04116151
Study type Interventional
Source Hospital Universitario Reina Sofia de Cordoba
Contact
Status Completed
Phase N/A
Start date July 19, 2022
Completion date July 30, 2023